© 2018 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#hepatitis B

Half of the 850,000 Americans With Hepatitis B Are Asian
Hepatitis B Testing 101
Treatment for Hepatitis B

Starting HIV Treatment With Higher CD4s Tied to Better Immune Rebound

Those who begin antiretrovirals with a higher CD4 count and CD4 to CD8 ratio are more likely to experience immune recovery.

The Liver Meeting 2018 Roundup

A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco

The Quest for a Hepatitis B Cure Continues

The liver virus affects as many as one in four people worldwide.

Many People With HIV May Have Undiagnosed Fatty Liver Disease

A considerable proportion of a group of people receiving HIV care had signs of the disease, but only a small group was diagnosed.

Vosevi Works Well as Retreatment of Hepatitis C

In a recent trial, Gilead’s regimen was highly successful in a group that included those with and without HIV coinfection.

Liver Cancer and Hepatitis B

Treating HIV Early Lowers Liver Fibrosis Risk

This is according to the large randomized controlled START trial.

Hepatitis B Highlights From the 2018 Liver Meeting

A review of some of the the latest research relating to hepatitis B presented at the annual Liver Meeting.

Liver Disease May Raise Risk for Drug-Induced Liver Injury

One researcher argues that the pharmaceutical industry ought to pay greater heed to such risks during drug development.

Hepatitis B, C and HIV

The latest research on hepatitis C treatment for people who are infected with HBV, HCV, and HIV.

Switching to New Version of Antiretroviral Tenofovir May Lead to Weight Gain

Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.

Hot topics

Preventing Hepatitis B
Find Help Paying for Treatment

Hepatitis B and C: What You Don’t Know May Hurt You

Essential info for anyone who is hepatitis B core antibody-positive, surface antigen-negative, and surface antibody-positive or negative.

Those Who Clear Hepatitis B Still Face Liver Cancer Risk

Although the risk is low, periodic medical monitoring for liver cancer among those with hepatitis B surface antigen clearance is advised.

A Look at One Data Scientist’s Efforts to Eliminate Hepatitis B by 2030

Stanford’s Mehlika Toy is working with the World Health Organization to determine what it will take to stop the liver virus in its tracks.

Have you been vaccinated against hepatitis B?

Hep C’s Fatigue, Mood, Cognitive Symptoms May Be Autoimmune Related

Researchers sought to deduce what drives these symptoms by comparing people with hep C with those who have other liver diseases.
Advertisement
Treatment News
Newsfeed